Australian Gonococcal Surveillance Program, 1 October to 31 December 2024
Monica M Lahra1,2, Sebastiaan Van Hal3, Tiffany R Hogan1
1The World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, NSW Health Pathology, Microbiology, Prince of Wales Hospital, Randwick, NSW 2031, Australia.
Communicable Diseases Intelligence (2018)
|July 30, 2025
Summary
The Australian Gonococcal Surveillance Programme (AGSP) monitors antimicrobial resistance in gonorrhea. This report details surveillance data from October to December 2024, crucial for public health.
Area of Science:
- Public Health
- Microbiology
- Epidemiology
Background:
- The Australian National Neisseria Network (NNN) collects antimicrobial susceptibility data.
- This data supports the Australian Gonococcal Surveillance Programme (AGSP).
Purpose of the Study:
- To present national gonococcal antimicrobial resistance surveillance data.
- To report findings for the period of 1 October to 31 December 2024.
Main Methods:
- Data collection through reference laboratories across Australian states and territories.
- Antimicrobial susceptibility testing for agreed antimicrobial agents.
- Quarterly and annual reporting of AGSP data.
Main Results:
- National gonococcal antimicrobial resistance surveillance data.
- Specific findings for the fourth quarter of 2024.
Conclusions:
- Ongoing surveillance is essential for tracking antimicrobial resistance trends.
- Data informs treatment guidelines and public health strategies for gonorrhea control.
Related Concept Videos
01:26Principles of Disease Surveillance
182
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
182
01:19Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996
01:26Sexually Transmitted Infections
415
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
415
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
41
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
41
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
40
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
40
01:22Healthcare Associated Infections II: Preventive Measures
2.8K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.8K